Dr. Öğr. Üyesi YÜKSEL BALCI
- Yöksis ID 137862
- Researcher ID KAU-4539-2024
- ORCID ID 0000-0003-1758-9600
- Scopus ID 35788701900
- Scholar ID e7iNSM8AAAAJ
- E-posta yukselbalci@mersin.edu.tr
- Dahili Telefon
Birim
TIP FAKÜLTESİ
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
RADYOLOJİ ANABİLİM DALI
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
RADYOLOJİ ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Radyoloji
Radyoloji
Son 5 Makale
Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF): Real-World outcomes from a Single-Center study
Lung India, vol. 43, no. 1, pp. 14–19 Link 2026
Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study
SCIENTIFIC REPORTS, vol. 16, no. 1, pp. – Link 2025
Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study
Scientific Reports, vol. , no. , pp. – Link 2025
A Case of Presumptive Lophomonas Pneumonia in an Immunocompetent Man Presenting with Hemoptysis
MIKROBIYOLOJI BULTENI, vol. 59, no. 3, pp. 413–423 Link 2025
Hemoptizi ile Başvuran İmmünkompetan Bir Erkekte Olası Lophomonas Pnömonisi: Olgu Sunumu
Mikrobiyoloji Bülteni, vol. 59, no. 3, pp. 413–423 Link 2025
Lung India, vol. 43, no. 1, pp. 14–19 Link 2026
Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study
SCIENTIFIC REPORTS, vol. 16, no. 1, pp. – Link 2025
Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study
Scientific Reports, vol. , no. , pp. – Link 2025
A Case of Presumptive Lophomonas Pneumonia in an Immunocompetent Man Presenting with Hemoptysis
MIKROBIYOLOJI BULTENI, vol. 59, no. 3, pp. 413–423 Link 2025
Hemoptizi ile Başvuran İmmünkompetan Bir Erkekte Olası Lophomonas Pnömonisi: Olgu Sunumu
Mikrobiyoloji Bülteni, vol. 59, no. 3, pp. 413–423 Link 2025
Son 5 Bildiri
The presence of coronary artery calcification on computed tomography and its impact on early outcomes in patients with pulmonary thromboembolism
( - ) Link 2025
Antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF):similarities and differences
( - ) Link 2025
Missing Group in Classification of Pulmonary Thromboembolism Severity and the Risk of Early Death: Real-life Experience
European Respiratory Society 2025 Congress (27.09.2025 - 01.10.2025) Link 2025
Antifibrotik tedavi alan idiyopatik pulmoner fibrosis ve progresif pulmoner fibrozis hastalarının klinik ve fonksiyonel özellikleri: 6. Ay ve 1. Yıl Takip Sonuçları
Türk Toraks Derneği 28. Yıllık Kongresi (23.04.2025 - 27.04.2025) Link 2025
Antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF):similarities and differences
European Respiratory Society (18.11.2025 - ) Link 2025
( - ) Link 2025
Antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF):similarities and differences
( - ) Link 2025
Missing Group in Classification of Pulmonary Thromboembolism Severity and the Risk of Early Death: Real-life Experience
European Respiratory Society 2025 Congress (27.09.2025 - 01.10.2025) Link 2025
Antifibrotik tedavi alan idiyopatik pulmoner fibrosis ve progresif pulmoner fibrozis hastalarının klinik ve fonksiyonel özellikleri: 6. Ay ve 1. Yıl Takip Sonuçları
Türk Toraks Derneği 28. Yıllık Kongresi (23.04.2025 - 27.04.2025) Link 2025
Antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF):similarities and differences
European Respiratory Society (18.11.2025 - ) Link 2025